... the vaccine formula can be done relatively easily, according to Dr. Zucai Suo, an eminent professor in biomedical science at Florida State University.
News
- Mutations 'have clinical consequences': J&J vaccine less effective against COVID variant
- A look at COVID-19 vaccines already in use, or getting close
Bharat Biotech: Authorized in India. Johnson & Johnson: In development; one dose; expected to seek U.S. Food and Drug Administration authorization ...
- Initial public offerings scheduled to debut next week
Evaxion Biotech - Copenhagen, Denmark, 2.8 million shares, priced $10-$12, managed by Oppenheimer & Co/Ladenburg Thalmann. Proposed ...
- As scientists turn their attention to COVID-19, other research is not getting done - and that can have ...
In biomedicine, academic labs study a specific topic and are led by experienced scientists who direct trainees. Over several years of training, a select ...
- Chevron, Johnson & Johnson fall; Novavax, Skyworks rise
The biotechnology company released encouraging results for a potential COVID-19 vaccine. Robert Half International Inc., up $2.70 to $67.50.